The global preclinical imaging market is experiencing steady growth, driven by rising investments in pharmaceutical research and development (R&D), increasing demand for advanced drug discovery tools, and continuous technological advancements in biomedical imaging. According to Grand View Research, the market is expanding as pharmaceutical companies, biotechnology firms, and research...